BioLife Corporate Profile
Financials
2018 Annual Revenue
$11.22 Billion
2018 Gross Profit
$5.97 Billion
2018 Annual Net Income
$1.34 Billion
2018 Fiscal Year
3.05%
Credit Rating
guaranteed by Baxalta, Inc., which senior unsecured notes are Investment Grade BBB+ by S&P
BioLife Corporate Profile
Baxalta is a bio-pharmaceutical company which was founded in 2015. That same year, Baxalta was acquired by Shire PLC (SHPGF), a biotechnology company focused on serving people with rare diseases and other specialized conditions worldwide. The company markets its products through wholesalers, distributors, and pharmacies.